West Pharmaceutical Services IncWST

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$373.60
Market cap
$26.3B
P/E
46.6x
Revenue (TTM)
$3.3B
Net income
$564.9M
Dividend yield
0.24%
1-year total return
47.3%
Net margin
17.0%
Revenue growth
12.4%
Debt / equity
0.07x

What West Pharmaceutical Services Inc does.

We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions. Our customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies in the world. Our top priority is delivering quality products that meet the exact product specifications and quality standards customers require and expect. This focus on quality includes a commitment to excellence in manufacturing, scientific and technical expertise and management, which enables us to partner with our customers in order to deliver safe, effective drug products to patients quickly and efficiently.

Our business operations are organized into two global business segments, Proprietary Products and Contract-Manufactured Products.

Our Proprietary Products reportable segment offers elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. Our packaging products include stoppers and seals for injectable packaging systems, which are designed to help ensure drug compatibility and stability with active drug products, while also supporting operational efficiency for customers. These packaging products also include syringe and cartridge components, including custom solutions for the specific needs of injectable drug applications, as well as administration systems that can enhance the safe delivery of drugs through advanced reconstitution, mixing and transfer technologies. We also provide films, coatings, washing, vision inspection and sterilization processes and services to enhance the quality of our packaging products and mitigate the risk of contamination and compatibility issues.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$2.1B$2.8B$2.9B$2.9B$2.9B$3.1B
Net income$346.2M$661.8M$585.9M$593.4M$492.7M$493.7M
Free cash flow$298.1M$330.6M$439.4M$414.5M$276.4M$468.9M

More on WST.

Figures from West Pharmaceutical Services Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.